Friday
SESSION 76: CAROTID TOPICS RELATED TO TRIALS, TIMING OF CEA, CONTROVERSIES, DIFFERING RISKS
Location: Grand Ballroom East, 3rd Floor
Moderators:Jon S. Matsumura, MD / Frank J. Veith, MD  
SESSION 76 SCHEDULE
2:01 PM - 2:06 PM Update On The ACST 2 RCT Comparing CAS And CEA In Patients With Asymptomatic Carotid Stenosis: Will Improvements In CAS Invalidate The Results In The First 2500 Randomized Patients
  Presenter(s):Alison Halliday, MS, FRCS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:07 PM - 2:12 PM Status Of The ECST 2 RCT Comparing Revascularization (CEA Or CAS) And Best Medical Treatment (BMI) To BMT Alone In Symptomatic And Asymptomatic Carotid Stenosis Patients: What Does It Tell Us To Date And What Will It Tell Us
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS / Martin M. Brown, MD / Leo H. Bonati, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:13 PM - 2:18 PM Status Of The CREST 2 Two Armed RCT: 1) CAS With BMT vs. BMT Alone; And 2) CEA With BMT vs. BMT Alone In Asymptomatic Patients With High-Grade (>70%) Carotid Stenosis: What Will It Tell Us And When
  Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:19 PM - 2:24 PM Why CREST 2 May Have Little Value In Guiding Treatment Of Carotid Stenosis In Asymptomatic Patients: Especially If Results Are Negative
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:25 PM - 2:30 PM Why CREST 2 May Not Help Us Much With Treatment Decisions In Asymptomatic Carotid Stenosis Patients: But It Still May Be Bad For CAS
  Presenter(s):Mark H. Wholey, MD / Kumar Pilai, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:31 PM - 2:36 PM RCTs Comparing CEA And CAS In Symptomatic Patients Are Invalidated By The Delays Between Symptom Onset And Revascularization
  Presenter(s):Gert J. de Borst, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:37 PM - 2:43 PM Panel Discussion
2:44 PM - 2:49 PM What Valuable Information Has The CREST Trial Provided: What Are The Prospects That CREST 2 Will Be Helpful
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:50 PM - 2:55 PM Single TIAs vs. Multiple Or Crescendo TIAs Are 2 Different Diseases Requiring Different Treatment Strategies: What Are These Strategies
  Presenter(s):Andrea Stella, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
TIMING OF CEA AFTER SYMPTOM ONSET
2:56 PM - 3:01 PM DEBATE: Best Medical Treatment With Antiplatelet Agents And Statins Decrease Recurrent Neurological Events After An Index Symptom Event With Carotid Stenosis: But It Does Not Change The Need To Perform Early CEA After Symptom Onset
  Presenter(s):Ross Naylor, MD, FRCS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:02 PM - 3:07 PM DEBATE: CEA Should Be Delayed At Least 2 Weeks After The Index Symptom Event: Why And What Are The Exceptions
  Presenter(s):Martin Bjorck, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:08 PM - 3:13 PM Delayed vs. Early Intervention (CEA/CAS) In Patients With Carotid Stenosis And Recent Strokes: Patients Should Be Individualized: In What % Is The Stroke Not Due To The Carotid Lesion
  Presenter(s):Tommaso Donati, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:14 PM - 3:19 PM In Patients Undergoing CEA Or CAS For A Stroke The Volume Of The Ischemic Lesion On CT Or MRI Correlates With A Poor Outcome: If The Stroke Is Large Revascularization Should Be Delayed
  Presenter(s):Andrea Stella, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:20 PM - 3:28 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 76
previous next